Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 19:6:25.
doi: 10.1186/1742-6405-6-25.

Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review

Affiliations

Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review

Ramachandran Meenakshisundaram et al. AIDS Res Ther. .

Abstract

Background: Snake and insect venoms have been demonstrated to have beneficial effects in the treatment of certain diseases including drug resistant human immunodeficiency virus (HIV) infection. We evaluated and hypothesized the probable mechanisms of venoms against HIV.

Methods: Previous literatures published over a period of 30 years (1979-2009) were searched using the key words snake venom, insect venom, mechanisms and HIV. Mechanisms were identified and discussed.

Results & conclusion: With reference to mechanisms of action, properties and components of snake venom such as sequence homology and enzymes (protease or L-amino acid oxidase) may have an effect on membrane protein and/or act against HIV at multiple levels or cells carrying HIV virus resulting in enhanced effect of anti-retroviral therapy (ART). This may cause a decrease in viral load and improvement in clinical as well as immunological status. Insect venom and human Phospholipase A2 (PLA2) have potential anti-viral activity through inhibition of virion entry into the cells. However, all these require further evaluation in order to establish its role against HIV as an independent one or as a supplement.

PubMed Disclaimer

References

    1. Koh D, Armugam A, Jeyaseelan K. Snake venom components and their applications in biomedicine. Cell Mol Life Sci. 2006;63(24):3030–3041. doi: 10.1007/s00018-006-6315-0. - DOI - PMC - PubMed
    1. Patlak M. From viper's venom to drug design: treating hypertension. FASEB J. 2004;18(3):421. doi: 10.1096/fj.03-1398bkt. - DOI - PubMed
    1. Marsh NA. Diagnostic uses of snake venom. Haemostasis. 2001;31(3-6):211–217. - PubMed
    1. Chen ZX, Zhang HL, Gu ZL, Chen BW, Han R, Reid PF, Raymond LN, Qin ZH. A long-form alpha-neurotoxin from cobra venom produces potent opioid-independent analgesia. Acta Pharmacol Sin. 2006;27(4):402–408. doi: 10.1111/j.1745-7254.2006.00293.x. - DOI - PubMed
    1. Pu XC, Wong PT, Gopalakrishnakone P. A novel analgesic toxin (hannalgesin) from the venom of king cobra (Ophiophagus hannah) Toxicon. 1995;33(11):1425–1431. doi: 10.1016/0041-0101(95)00096-5. - DOI - PubMed

LinkOut - more resources